On April 28, 2008, a Digitek (digoxin tablets) recall was announced for the heart medication sold throughout the United States under the “Bertek” and “UDL” labels. Experienced attorneys at the law firm of Houssiere, Durant & Houssiere, LLP are actively reviewing potential Digitek (digoxin tablets) lawsuits throughout the United States.

Individuals who have suffered a stroke or death as a result of digitalis toxicity may be entitled to financial compensation. Digitek (digoxin tablets) was recalled because the tablets may be twice as thick, and contain double the dose of medication than it should. The stronger tablets may cause toxicity in renal-failure patients, stroke and/or death. On May 9, 2008 the Wall Street Journal published an article discussing the dangers of the Digitek (digoxin tablets) which can be viewed by clicking here.

Digitek Recall

Digitek tablets are prescribed for treatment of heart failure and abnormal heart rhythms. The generic form of digitalis were manufactured by Actavis Totowa, formerly known as Amide Pharmaceutical, Inc., a division of Actavis Group. The tablets were distributed by Mylan Pharmaceuticals, Inc. under the “Bertek” label and by UDL Laboratories, Inc. under the “UDL” labels. Reports suggest that the defective Digitek tablets may have been sold for over a year. The Digitek recall has been classified as a Class 1 Recall, which means that the product poses a substantial risk of serious injury or death. For individuals with renal failure or impaired kidney function, they could suffer from a potentially fatal illness known as Digitalis Toxicity. This occurs when excessive amounts of digitalis accumulates in the body. Symptoms of a Digitalis Toxicity immediately before death or stroke could include:

• vomiting
• nausea
• dizziness
• low blood pressure
• cardiac instability
• bradycharida.

Experienced attorneys at the law firm of Houssiere, Durant & Houssiere, LLP are actively reviewing potential individual lawsuits on behalf of individuals who received a prescription for Digitek (digoxin tablets) since 2006 and required medical treatment as a result of digitalis toxicity. Negligence in the manufacturing process has exposed people, particularly those with renal impairment, to a risk of serious and potentially fatal illness. If you, a friend or family member have received medical treatment associated with digitalis toxicity after taking Digitek tablets, contact us to request a free Digitek lawsuit evaluation. There are no fees or expenses unless a recovery is obtained.